Latest / Booker Scott: Truth Be Told / The Vax Injured Have Some Hope
Transcript
- 0:07Speaker 1: It's 6 Eastern. It's 3 o'clock Pacific. We will draw
- 0:10Speaker 1: this city closer together.
- 0:12Speaker 2: Coast to coast and around the world from the America
- 0:15Speaker 2: Out Loud talk radio studios. We will replace the frigidity
- 0:19Speaker 2: of rugged individualism with the warmth of collectivism. It's time
- 0:22Speaker 2: for The Truth Be Told with Booker Scott. Thousands of
- 0:27Speaker 2: people still suffer today from vaccine injuries taken from the
- 0:31Speaker 2: COVID vaccine. Before that, there were vaccine injuries of many types.
- 0:37Speaker 2: What is the answer? How do we get help with this?
- 0:40Speaker 2: Because I've had many people on this program that have
- 0:43Speaker 2: suffered from vaccine injuries. I've also had someone a few
- 0:46Speaker 2: times who works in that field. Her name is Dr.
- 0:49Speaker 2: Irene Mavrikakis. She's a friend of mine, an associate, a
- 0:53Speaker 2: colleague in Liberty, and we have her back on the
- 0:56Speaker 2: program tonight. I'm Booker, and this is The Truth Be Told. Irene, Dr.
- 1:00Speaker 2: Irene Mavrikakis, welcome back to the program. It's great to
- 1:03Speaker 2: have you.
- 1:04Speaker 3: Booker. Well, thank you so much for having me on
- 1:06Speaker 3: to discuss this important topic.
- 1:09Speaker 2: Yeah, it is important. And you know, when the COVID
- 1:11Speaker 2: vaccine came out, and I think died suddenly, the whole
- 1:15Speaker 2: died suddenly thing, I think it kind of wasn't real helpful.
- 1:20Speaker 2: Because so many people thought that if you took the
- 1:22Speaker 2: vaccine that you died. So many people thought if you
- 1:25Speaker 2: took the vaccine, then you got myocarditis. And that's really
- 1:29Speaker 2: just not even close to the truth. But I think
- 1:31Speaker 2: there are people that still believe that. And I think
- 1:33Speaker 2: in some ways, people that claim to have a vaccine
- 1:37Speaker 2: injury from COVID vaccine or any others, I believe that
- 1:41Speaker 2: clouded the water for those people. Because you and I,
- 1:44Speaker 2: it's your business. It's what you do in the medical field.
- 1:47Speaker 2: And I've had people on this program before that suffer
- 1:50Speaker 2: from the COVID vaccine injury. We know that it's real
- 1:54Speaker 2: and it's affecting people's lives. And I think all of
- 1:57Speaker 2: that died suddenly stuff, I think it kind of hurt
- 2:01Speaker 2: the people that are really hurt from vaccine injuries. And
- 2:04Speaker 2: I've said this before when you've been on the program,
- 2:06Speaker 2: you are someone that was vax injured yourself many years ago.
- 2:10Speaker 2: This was going back 13, 14 years ago. Since that time,
- 2:13Speaker 2: you have made it a part of your practice. And
- 2:15Speaker 2: now you're trying to get into it a little bit
- 2:17Speaker 2: deeper to try to find some answers for these people
- 2:20Speaker 2: that were injured during the COVID vaccine.
- 2:23Speaker 3: Well, yeah, you make some good points. Yeah, I was
- 2:26Speaker 3: vaccine injured in 2012 and was really sick for over
- 2:32Speaker 3: eight years and found my way back to health from
- 2:35Speaker 3: a combination of allopathic medicine and complementary and alternative medicine
- 2:41Speaker 3: and some interesting nutritional changes. But I was a frequent
- 2:45Speaker 3: flyer in the emergency room for a long time. And inadvertently,
- 2:50Speaker 3: through my practice as an interventional spine and musculoskeletal specialist
- 2:55Speaker 3: over the years, vaccine injured patients will present as musculoskeletal
- 3:01Speaker 3: or neurological pain, things like CIDP, which is chronic immune
- 3:06Speaker 3: demyelinating polyneuropathy. It presents with pain and weakness in the legs,
- 3:11Speaker 3: but often they get referred for a spine condition. And
- 3:15Speaker 3: so over the years, I wound up figuring it out
- 3:18Speaker 3: that some of these people have vaccine injury. There's a
- 3:22Speaker 3: condition called adhesive capsulitis or frozen shoulder, but some of
- 3:26Speaker 3: these people, the timeline is three weeks to three months
- 3:31Speaker 3: after a vaccine. And it's really shoulder injury related to
- 3:35Speaker 3: vaccine administration or called server. And it's a compensable vaccine
- 3:39Speaker 3: injury on the traditional vaccine adverse event reporting system vaccine injury. which,
- 3:45Speaker 3: of course, we have this health care compensation fund to
- 3:49Speaker 3: pay injuries because vaccine makers have product liability protection from
- 3:53Speaker 3: a 1986 law. So you make a lot of good
- 3:56Speaker 3: points to the extent by which we focus too much
- 3:59Speaker 3: on the people dying from them. But what I've been
- 4:01Speaker 3: saying to people recently, and I think this is a
- 4:04Speaker 3: good point, and you can tell me if you think
- 4:05Speaker 3: it is or not.
- 4:06Speaker 2: You know I will.
- 4:09Speaker 3: If you all can accept people on daily medications, that
- 4:14Speaker 3: come into my office and they talk about, I think
- 4:16Speaker 3: I'm having a side effect. And if we're supposed to
- 4:19Speaker 3: explain risks and benefits and side effects of medications, and
- 4:23Speaker 3: we acknowledge that patients have side effects from oral medications
- 4:26Speaker 3: and doctors take patients off of medications all the time
- 4:30Speaker 3: from side effects. Not just allergy, which is a whole
- 4:32Speaker 3: other thing, because there's an allergy component with these vaccines
- 4:36Speaker 3: that can happen in the patients. And there's a histamine-related
- 4:40Speaker 3: vaccine adverse reaction. And we acknowledge all of that. So
- 4:44Speaker 3: I don't understand what kind of cognitive dissonance the world has,
- 4:49Speaker 3: or my physician colleagues for the most part, to think
- 4:52Speaker 3: that injecting something into a human or a baby can't
- 4:55Speaker 3: possibly have side effects that we'd want to assess, diagnose,
- 4:59Speaker 3: and treat. So I don't understand what is wrong with
- 5:02Speaker 3: the world regards to this. I don't know why everybody
- 5:05Speaker 3: has their head in the sand about it. But if
- 5:07Speaker 3: we acknowledge it for something taken orally, it's much more
- 5:10Speaker 3: an offensive event to the human body when you inject something.
- 5:15Speaker 2: I can't push back because I agree with everything you said.
- 5:17Speaker 2: A vaccine is nothing more than a medicine. And if
- 5:21Speaker 2: you watch television and you see these 30-second commercials for
- 5:24Speaker 2: pharmaceutical companies and new medications, It's 25 seconds of a disclaimer,
- 5:29Speaker 2: and most of which I don't want any of those
- 5:31Speaker 2: side effects. And if you only listen to the side
- 5:35Speaker 2: effects that come with most of these medications, you probably
- 5:37Speaker 2: wouldn't take the medication either. But I guess sometimes we
- 5:40Speaker 2: need the medication to keep us alive. And I guess
- 5:42Speaker 2: some would argue that these vaccines are maybe in that category.
- 5:47Speaker 2: I know some people argue that. I know some are
- 5:49Speaker 2: against them totally. I don't necessarily think that's the best idea,
- 5:54Speaker 2: I think. There are some good vaccines. They have been
- 5:57Speaker 2: proven like polio through the years that they're good vaccines.
- 6:00Speaker 2: But even those have side effects. And for some reason,
- 6:04Speaker 2: like you said, the medical professionals. They buried their head
- 6:08Speaker 2: in the sand or didn't want to talk about it.
- 6:10Speaker 2: Who knows why, whether it was political coming from up above,
- 6:13Speaker 2: the pharmaceutical companies, wherever it was, they didn't want to
- 6:17Speaker 2: admit what was actually happening. And when you give as
- 6:20Speaker 2: many people as we did a shot, a vaccine, then
- 6:24Speaker 2: you're going to see big numbers. And we saw big numbers,
- 6:26Speaker 2: whether it was people dying, turbo cancers now and Then
- 6:30Speaker 2: people that you work with every day, those that have
- 6:32Speaker 2: been vaccine injured, and I've had them on the show before,
- 6:35Speaker 2: and they've talked about, well, literally within 24 hours of
- 6:39Speaker 2: taking the COVID vaccine, they were feeling it. They knew
- 6:42Speaker 2: something was wrong. They were becoming sick, and they really
- 6:45Speaker 2: don't have any solutions and answers for them. But that's
- 6:48Speaker 2: what you're trying to work on is finding a cure
- 6:51Speaker 2: for these people. And many of them are walking around
- 6:54Speaker 2: in society today that are still suffering from the vaccine
- 6:57Speaker 2: injury from COVID. What you are doing right now is
- 7:00Speaker 2: the Vaccine Injury Treatment Center of Excellence and Research. And
- 7:05Speaker 2: this is a clinical trial consortium that you're putting together.
- 7:09Speaker 2: Liberty Speaks is. And you are working with many doctors.
- 7:12Speaker 2: I think it's over 50 that you have put together
- 7:15Speaker 2: to try to work something out to try to help
- 7:17Speaker 2: these people. Talk about it a little bit. Talk about
- 7:20Speaker 2: what you're trying to accomplish here.
- 7:22Speaker 3: Yeah, so the point of the consortium is that we
- 7:25Speaker 3: already have doctors and allied health professionals who have been
- 7:31Speaker 3: treating both the COVID vaccine injury, and COVID vaccine is
- 7:35Speaker 3: really a biologic, but we won't get stuck on that,
- 7:38Speaker 3: and long COVID, which is all in the same spectrum,
- 7:42Speaker 3: and then the other types of vaccine injuries, some of
- 7:45Speaker 3: them for more than a decade. But we don't have
- 7:49Speaker 3: clinical trials for the most part. And it's interesting, if
- 7:54Speaker 3: we want to say that the medical freedom movement and
- 7:57Speaker 3: truth in medicine movement is about science, then we have
- 8:01Speaker 3: to have clinical trials, A, because we have to show
- 8:04Speaker 3: the data and demonstrate that it's efficacious. And then we
- 8:09Speaker 3: have to be able to share that so we can
- 8:11Speaker 3: give treatment more broadly across the country. So the treatment
- 8:15Speaker 3: for vaccine injury, and I lived it myself, and it's
- 8:18Speaker 3: still the case, is very haphazard. It's difficult. It's not standardized.
- 8:23Speaker 3: So a lot of the protocols, and we can go
- 8:26Speaker 3: through them, have been used by various physicians for treatment
- 8:30Speaker 3: for a long time, but we don't have the clinical trials.
- 8:34Speaker 3: And that's the point to talk about is, you know, well,
- 8:37Speaker 3: why wouldn't they have rushed to do clinical trials either
- 8:42Speaker 3: recently or previously? And I have been bothering the administration
- 8:49Speaker 3: through public and internal channel because what I wanted was
- 8:54Speaker 3: a National Institute of Health Vaccine Injury Center Treatment and
- 9:00Speaker 3: Consortium so that we would go through the NIH.
- 9:06Speaker 2: Irene, is there not a place where these different treatments
- 9:10Speaker 2: are aggregated so that others can see what other doctors
- 9:14Speaker 2: are doing? Is that a part of the problem as well?
- 9:17Speaker 3: Well, yeah. So these doctors in the consortium, and there's
- 9:20Speaker 3: others that we haven't brought in, which we're working on,
- 9:23Speaker 3: are all across the country doing their protocols. And they
- 9:26Speaker 3: have data. You know, they are paying attention to their
- 9:29Speaker 3: own data. And they are showing a lot of positive
- 9:33Speaker 3: results both in symptomatology, the patient's symptoms, and in laboratory values,
- 9:40Speaker 3: which is why I formed the consortium. And there's no...
- 9:45Speaker 3: ability currently in the political climate of the current administration
- 9:50Speaker 3: for a vaccine injury treatment center and clinical trial consortium
- 9:56Speaker 3: to come out of the NIH. It's not happening right now.
- 10:02Speaker 3: And so as a libertarian, I made a decision maybe
- 10:06Speaker 3: six months ago that we don't really need the government
- 10:10Speaker 3: to do clinical trials. And I need to expand on
- 10:13Speaker 3: that because you kind of do. the way things are
- 10:17Speaker 3: right now.
- 10:17Speaker 2: Yeah, there's three different ways for clinical trials. So talk
- 10:22Speaker 2: about that a little bit because it's not cheap to do.
- 10:26Speaker 2: You're doing a fundraiser and you're doing really well on
- 10:29Speaker 2: that fundraiser too, by the way. We're going to talk
- 10:31Speaker 2: about that, give people an opportunity to maybe help you
- 10:35Speaker 2: out if they feel like it's something they want to do.
- 10:37Speaker 2: But talk about that process, the approval, the IRB approval process.
- 10:43Speaker 1: Yeah, so.
- 10:45Speaker 3: Well, let me go back to the three ways to
- 10:48Speaker 3: run clinical trials. So there's industry-funded, which is like pharma industry-funded,
- 10:54Speaker 3: and they're significantly more likely to get published and often
- 10:57Speaker 3: show positive results. So that's like big pharma, like industry pharma.
- 11:02Speaker 3: I don't really think we're going to get funding from
- 11:04Speaker 3: big pharma, at least not the traditional big pharma.
- 11:07Speaker 2: Yeah, I wouldn't think so, no. Yeah.
- 11:10Speaker 3: And then there's academic centers, but they're very much about
- 11:15Speaker 3: publish and perish. And there's a lot of influences. It
- 11:19Speaker 3: would be unlikely for us to do that. I mean,
- 11:22Speaker 3: we're open to going to all these pathways and then self-funded,
- 11:26Speaker 3: very rare programs. And there's two aspects of where you
- 11:31Speaker 3: need to get the money from. So the first basic
- 11:35Speaker 3: thing that we need to do is IRB, Institutional Review
- 11:39Speaker 3: Board approval. So we're working with an independent IRB. And
- 11:44Speaker 3: what that is, is really a group of people approve
- 11:47Speaker 3: it more from like, is this... Is it the protocol
- 11:52Speaker 3: given informed consent? Is human subject treatment appropriate and ethical
- 11:56Speaker 3: and follows all the code of ethics? You know, that
- 12:00Speaker 3: kind of should this even be done? And so the
- 12:04Speaker 3: review board typically costs around thirty five hundred dollars per
- 12:08Speaker 3: clinical trial just to get approval to proceed with. And
- 12:12Speaker 3: you're never going to get grants from anywhere if you
- 12:15Speaker 3: don't have IRB approval. You can't do the clinical trial.
- 12:19Speaker 2: So that's sort of the first step. The first step
- 12:21Speaker 2: then is that, and it costs $ 3, 500 just to get
- 12:25Speaker 2: into the door, just to get this approval. And then
- 12:28Speaker 2: that approval then can take you further.
- 12:31Speaker 1: Right.
- 12:31Speaker 3: And then once you're approved, then you can apply for
- 12:33Speaker 3: grant money. So the idea is that we want multi-center trials, right?
- 12:37Speaker 3: So we have physicians all over the country. We have
- 12:40Speaker 3: draft trials. And I'd like to go through the draft
- 12:43Speaker 3: trials briefly and explain them. There's one that's really important.
- 12:49Speaker 3: They're doing patients in Japan with this one trial. And
- 12:52Speaker 3: so then once you get IRB approval, then you apply
- 12:55Speaker 3: to grants. And we know where the grant money is
- 12:58Speaker 3: and we know where we're going to apply to. for
- 13:01Speaker 3: the grants and there's definitely a lot of opportunities including
- 13:06Speaker 3: government grants. So I'm not saying that we're not gonna
- 13:10Speaker 3: be able to get grants from the NIH and other
- 13:12Speaker 3: places and private grants. So we have that all kind
- 13:15Speaker 3: of worked out where we're gonna go once we get
- 13:18Speaker 3: IRB approval. I won't discuss any more details about that. But,
- 13:23Speaker 3: you know, clinical trials can cost $ 500, 000 a million, depending
- 13:28Speaker 3: on what we're doing. It's a lot of money. So,
- 13:31Speaker 3: I mean, to be honest with you, as a libertarian,
- 13:33Speaker 3: if I had my druthers, I would crowdsource fund the
- 13:37Speaker 3: whole thing, you know, raise $ 20 million, build a couple
- 13:42Speaker 3: of brick and mortars. That's what I wanted at the NIH.
- 13:45Speaker 3: That's my dream.
- 13:46Speaker 1: But.
- 13:47Speaker 3: The writing was on the wall. I mean, I was
- 13:50Speaker 3: directly told that it needs to be done this way.
- 13:53Speaker 3: Decentralized private physicians. And that is quintessential libertarian, right? We
- 13:58Speaker 3: as physicians in this country can choose to find a
- 14:02Speaker 3: way to do clinical trials without the influences of the
- 14:05Speaker 3: powers that be that have been really not doing a
- 14:10Speaker 3: service to this country and ignoring the vaccine in Europe.
- 14:14Speaker 3: And it has to stop. And so as someone who
- 14:16Speaker 3: was vaccine injured myself and treating vaccine injuries for a
- 14:20Speaker 3: long time, it was my calling.
- 14:24Speaker 2: Well, we're glad you're doing it. And I hope that
- 14:26Speaker 2: you get enough money to get this off the ground.
- 14:29Speaker 2: I want to talk about that right now. This is Dr.
- 14:31Speaker 2: Irene Mavrikakis. Liberty Speaks, Inc. is the name of her 501c4.
- 14:37Speaker 2: She is trying to raise money to, you know, get
- 14:39Speaker 2: some help for the vaccine injured people that really are
- 14:42Speaker 2: just lost out there. They don't know where to go.
- 14:44Speaker 2: They don't know what kind of help they can get.
- 14:47Speaker 2: And Irene is one of those people that is working
- 14:50Speaker 2: with them every day. She's trying to pull this together.
- 14:53Speaker 2: And if you notice, she says consortium. I say consortium.
- 14:57Speaker 2: And we had this conversation before. We started this broadcast,
- 15:01Speaker 2: and we realized that we said it two different ways,
- 15:05Speaker 2: and both of us were like, well, which one is right?
- 15:08Speaker 2: And Irene went to artificial intelligence, and we found out
- 15:12Speaker 2: we're both right. So if you say consortium, you're okay,
- 15:15Speaker 2: and if you say it like I do, consortium, you're
- 15:18Speaker 2: okay too, but She's bringing together over 50 doctors together
- 15:22Speaker 2: to do this. It's not going to be cheap. As
- 15:24Speaker 2: you heard, it's $ 3, 500 just to get in the door. Irene,
- 15:28Speaker 2: tell everybody where to go and how to give, even
- 15:32Speaker 2: if it's just a little bit of money. If you're
- 15:34Speaker 2: interested in helping people that are vaccine injured, Irene, tell
- 15:37Speaker 2: them where people can go.
- 15:38Speaker 3: So we started a fundraiser on GiveButter. I've used them before,
- 15:43Speaker 3: so they don't steal your money. So we thought that
- 15:46Speaker 3: would be a good idea. So the Give Butter fundraiser
- 15:52Speaker 3: is run by Liberty Speaks, which is my 501c4, because
- 15:56Speaker 3: I deliberately didn't incorporate the consortium. So it's completely a
- 15:59Speaker 3: voluntary association. And there's a lot of reasons why we
- 16:03Speaker 3: did that. We want the physicians to maintain the independence.
- 16:06Speaker 3: But I needed a fiscal fundraising sponsor. And so, you know,
- 16:10Speaker 3: Liberty Speaks is a 501c4. That's a social justice organization. nonprofit.
- 16:16Speaker 3: And so 100% of the money that we raise goes
- 16:19Speaker 3: to the different types of IRB approvals for the different
- 16:25Speaker 3: draft trials. But the first one is what we call
- 16:28Speaker 3: Japan A trial, which I do want to talk about
- 16:30Speaker 3: maybe some of the other ones.
- 16:31Speaker 2: Yeah, we're going to get to it right after the break.
- 16:33Speaker 2: But give everybody the website real quick where to go.
- 16:36Speaker 2: You said give butter, let's say skip butter.com. And then
- 16:40Speaker 2: what else is after? What do they do? They go
- 16:42Speaker 2: look for it. Under your name, Liberty Speaks, or is
- 16:45Speaker 2: it GiveButter.com slash Liberty Speaks, something like that?
- 16:49Speaker 3: It's GiveButter.com, the Vaccine Injury Treatment Center of Excellence and
- 16:54Speaker 3: Clinical Trial Consortium. But what they can do is if
- 16:56Speaker 3: you go to my Twitter, at Irene Mavrikakis, it's up there.
- 17:02Speaker 3: And if you go to Liberty Speaks, which is at
- 17:04Speaker 3: National Speaks, and also Dr. Bowden has it up all
- 17:09Speaker 3: the time, there's links to the GiveButter. It's also on
- 17:15Speaker 3: Liberty Speaks, the promo videos on Liberty Speaks on Rumble,
- 17:20Speaker 3: on the Liberty Speaks Rumble page, the video that has
- 17:24Speaker 3: all the links with a Q code and things like that.
- 17:26Speaker 3: So if they find me there. Okay.
- 17:29Speaker 2: Her name is Dr. Irene Mavrikakis. We're up against a break.
- 17:31Speaker 2: We're going to take it right now. But when we
- 17:33Speaker 2: come back, we're going to talk about some of these
- 17:35Speaker 2: trials she's mentioned previously. Japan a trial. There's more than
- 17:40Speaker 2: that to discuss. We'll continue this conversation in minutes. More
- 17:44Speaker 2: truth in minutes on America Out Loud Talk Radio. Someone
- 17:48Speaker 2: asked me the other day, how do you even get
- 17:51Speaker 2: a sense of what's going to happen next? It's hard.
- 17:54Speaker 2: I don't know that we can the way the news
- 17:56Speaker 2: moves so fast. But you know what I told them?
- 17:59Speaker 2: I said, I've been checking out Polly Market a little bit.
- 18:02Speaker 2: It's extremely insightful. You're basically watching how thousands of people
- 18:07Speaker 2: are betting on outcomes. Political elections, big policy moves, even
- 18:12Speaker 2: events you wouldn't expect. It's kind of like a live
- 18:16Speaker 2: pulse on what the public actually believes. And you can
- 18:20Speaker 2: see trends before they even happen and before they even
- 18:24Speaker 2: make the mainstream news. For me, it's not about gambling.
- 18:29Speaker 2: It's about understanding the probabilities and where the momentum is shifting.
- 18:34Speaker 2: If you like or love the news like I do,
- 18:36Speaker 2: maybe you're a news junkie, but you want to take
- 18:38Speaker 2: a little deeper look at what people really think, go
- 18:41Speaker 2: to Polymarket. It's a fascinating tool. Polymarket.com. Welcome back to
- 18:58Speaker 2: The Truth Be Told here on America Out Loud Talk Radio.
- 19:01Speaker 2: I am Booker Scott. Thank you so much for joining
- 19:04Speaker 2: us tonight. And we're having a conversation about the vaccine injured.
- 19:07Speaker 2: There are so many of them out there, not just
- 19:10Speaker 2: COVID-19 vaccine injuries, but there are vaccine injuries from all
- 19:15Speaker 2: types of vaccines.
- 19:16Speaker 1: And Dr.
- 19:17Speaker 2: I noticed I say Maverick caucus. You say Maverick caucus.
- 19:20Speaker 2: So I'm going to go with you from now on.
- 19:22Speaker 2: I've always just called you Maverick caucus, but I will
- 19:26Speaker 2: go your way because it's your name. And I will
- 19:28Speaker 2: say your name the way that you pronounce it. So
- 19:31Speaker 2: we're talking about this Japan, a trial. You brought it
- 19:35Speaker 2: up a couple of times. Let's get into that. What
- 19:37Speaker 2: is that about? What are they trying to do? And
- 19:40Speaker 2: obviously they're trying to accomplish something. Let's talk about what
- 19:43Speaker 2: this is.
- 19:44Speaker 3: Yeah, so it's very important for people to understand, you know,
- 19:47Speaker 3: what do we even mean by vaccine injuries? So the
- 19:51Speaker 3: idea of vaccines is to make your immune system ready
- 19:56Speaker 3: for the subsequent illness by ramping it up. But sometimes
- 20:01Speaker 3: the immune system just keeps ramping up. And depending on
- 20:05Speaker 3: the situation, this is just in broad terms. And so
- 20:08Speaker 3: the ramp up could be autoimmune and the autoimmune could
- 20:13Speaker 3: attack your immune system. Like the classic vaccine injury that
- 20:16Speaker 3: everybody knows is Guillain-Barre, which is the ascending paralysis. And
- 20:20Speaker 3: they treat it with plasmapheresis and IV IgG. What does
- 20:23Speaker 3: that mean?
- 20:24Speaker 2: And a lot of people that took COVID-19, they got
- 20:26Speaker 2: that as well.
- 20:27Speaker 3: Yeah.
- 20:28Speaker 4: Yeah. Yeah.
- 20:29Speaker 1: Yeah.
- 20:29Speaker 3: But so the idea is you have all these immune
- 20:31Speaker 3: cells and they keep going. And then the cytokine storm
- 20:33Speaker 3: is really like the reaction that your body's trying to fight.
- 20:37Speaker 3: When you get sick, you get all snotty and everything.
- 20:39Speaker 3: And that's kind of like the basic premise of cytokine
- 20:43Speaker 3: storm and you get leaky vessels and all this kind
- 20:45Speaker 3: of stuff. But if it doesn't stop, you just lose
- 20:48Speaker 3: a lot of energy and a lot of nutrients and
- 20:50Speaker 3: a lot of electrolytes and it causes havoc and you
- 20:53Speaker 3: become not in biochemical order. So it's kind of like,
- 20:56Speaker 3: To pretend there's no vaccine injury is kind of stupid
- 20:59Speaker 3: because then you're pretending that you don't understand what the
- 21:01Speaker 3: point of what you were doing in the first place
- 21:03Speaker 3: with the vaccine was to ramp up the immune system.
- 21:06Speaker 3: But it doesn't have a lot of controls on it.
- 21:08Speaker 3: So inadvertently and expectedly, you're going to have problems, including allergy,
- 21:12Speaker 3: which is another component of the cytokine storm. And I
- 21:14Speaker 3: wrote a few papers on that stuff. And so what
- 21:17Speaker 3: is this about? So this particular Japan, a trial they're
- 21:22Speaker 3: doing the McCurran trial, they have, uh, up to 17 patient, uh,
- 21:28Speaker 3: is actually there now. She's starting treatment, uh, today in
- 21:32Speaker 3: Japan time, I believe. Um, and so the idea is
- 21:39Speaker 3: to clean all that cytokine stuff out and find these, um,
- 21:47Speaker 3: different things that happen as a consequence of the COVID shot,
- 21:51Speaker 3: which is a bioweapon, and clean out all of it.
- 21:57Speaker 3: And so it's plasma adsorption therapy is the first part,
- 22:03Speaker 3: dual filtration, clean out all the extra immune cells. It's
- 22:07Speaker 3: similar to plasmapheresis, but much more specific therapy. And it's
- 22:12Speaker 3: getting the amyloid out, all of these things you hear
- 22:16Speaker 3: on the internet about just your immune systems releasing all
- 22:19Speaker 3: these things. And then that's making you even sicker because
- 22:22Speaker 3: you're just, everything's going haywire. So it's called plasma absorption therapy, right?
- 22:28Speaker 3: And then the second part is so interesting because Dr.
- 22:32Speaker 3: Kato is the physician there and his family owns the hospital.
- 22:35Speaker 3: And they've been using both plasma absorption therapy and plasmapheresis
- 22:40Speaker 3: and these various things for decades. And the second half
- 22:44Speaker 3: of it is stem cells. Now, the stem cells in Japan,
- 22:49Speaker 3: their source is so interesting and I have a funny
- 22:52Speaker 3: epiphany related to it.
- 22:55Speaker 2: Go ahead. Because I think I know where you're going
- 22:57Speaker 2: because this caught my attention when I read through your paper.
- 23:01Speaker 3: And I'm so stuck on it. So I hope you
- 23:03Speaker 3: get stuck on it too because I find it so interesting.
- 23:06Speaker 3: People just roll their eyes. They're like, Dr. Mav, really?
- 23:09Speaker 3: I'm like, no, really. So because when we met with Dr.
- 23:12Speaker 3: Cato online, he said you want the most primordial basic
- 23:18Speaker 3: stem cells, right? The less, the more... less differentiated and
- 23:25Speaker 3: less antigenic, less allergy producing, less reactive, right? Stem cells,
- 23:31Speaker 3: basic stem cells, the better it is for the recovery.
- 23:34Speaker 3: That's me trying to explain something very complex. So in Japan,
- 23:38Speaker 3: primary tooth pulp stem cells is used all the time,
- 23:43Speaker 3: which is baby teeth, okay? And the reason why we
- 23:47Speaker 3: have Japan B trial is, I'll explain, it's because neither
- 23:51Speaker 3: one of these is FDA approved. But we have similar
- 23:54Speaker 3: in America. So I don't want to wait. So I
- 23:56Speaker 3: want to start potentially with Japan B, although the first
- 24:00Speaker 3: thirty five hundred dollars is going already. I already transferred
- 24:04Speaker 3: the money to Liberty Speaks bank account and I'll be
- 24:06Speaker 3: paying for their IRB in the next few days is
- 24:08Speaker 3: going to Japan A. So we can start working on
- 24:11Speaker 3: it because they have to do. a lot more approvals
- 24:14Speaker 3: because they have to do FDA issues and it's a
- 24:17Speaker 3: whole thing.
- 24:17Speaker 1: Okay.
- 24:18Speaker 2: So I want to stop you right here because you
- 24:20Speaker 2: haven't gotten into the tooth pulp stem cells enough for me.
- 24:24Speaker 2: You know how I am. So they come from baby teeth.
- 24:28Speaker 3: Yeah.
- 24:29Speaker 2: Okay. How much of this do you need? Because baby's
- 24:31Speaker 2: teeth are not very big. It doesn't seem like there
- 24:34Speaker 2: would be a lot of stem cells in there. How
- 24:37Speaker 2: does that work? Is there enough to create the protocol
- 24:41Speaker 2: for this treatment?
- 24:43Speaker 3: Yeah, I mean, they have a whole protocol in Japan,
- 24:45Speaker 3: and I don't know the details.
- 24:48Speaker 2: I didn't know if there were a lot of people
- 24:49Speaker 2: walking around Japan with no teeth because they use their
- 24:53Speaker 2: tooth pulp.
- 24:54Speaker 3: No, no, but baby teeth. Now think about our culture.
- 24:58Speaker 3: Think about what we do with baby teeth in our culture.
- 25:01Speaker 3: And what my hypothesis is, is our caveman ancestors probably
- 25:06Speaker 3: were using baby teeth stem cells, but now our materialistic
- 25:11Speaker 3: culture has the tooth fairy putting $ 2 under the pillow
- 25:14Speaker 3: for the, I, my hypothesis is that's where it came from.
- 25:18Speaker 3: And we knew some point, Right. Think about it. Why
- 25:22Speaker 3: the hell do we have the tooth fairy paying for
- 25:25Speaker 3: baby teeth?
- 25:26Speaker 2: I just thought it was a gimmick to get your
- 25:27Speaker 2: kids to act right. Just like Santa Claus and the others.
- 25:30Speaker 3: I don't know, but like, think about it. Like, did
- 25:34Speaker 3: we in the past, did we, did we historically forget?
- 25:39Speaker 3: Did our ancestors, I've been trying to look it up,
- 25:41Speaker 3: but you know, it's hard. I just, I just went
- 25:43Speaker 3: on this rabbit hole. Did they know, did our ancestors
- 25:47Speaker 3: take baby teeth, take this stuff out and grind it
- 25:49Speaker 3: up and, and, Use it for medicinal treatment. Did the
- 25:53Speaker 3: shaman use, like, I don't know, don't they all have
- 25:56Speaker 3: teeth around them? And when you look at Africa and
- 25:58Speaker 3: the shamans, don't they have?
- 25:59Speaker 2: Oh, they do, yeah.
- 26:00Speaker 5: Yes!
- 26:01Speaker 2: Yeah, you're right. I didn't think about it from that
- 26:04Speaker 2: aspect of it. But let me ask you this. How
- 26:07Speaker 2: did these people in Japan think of this?
- 26:10Speaker 3: They've been doing it for a long time.
- 26:12Speaker 2: I don't know. Maybe it's going all the way back
- 26:15Speaker 2: to the cavemen, then, possibly.
- 26:17Speaker 3: I don't know, but don't you think it's interesting? I do.
- 26:20Speaker 1: It's just wild.
- 26:20Speaker 2: That's why I've been talking about it for five minutes.
- 26:22Speaker 2: I saw this when I read through this, and I'm like,
- 26:25Speaker 2: I want to talk about this. I want to learn
- 26:26Speaker 2: more about this. But let's move on to Japan B trial.
- 26:29Speaker 2: You say you're going to forward them the money, $ 3, 500,
- 26:33Speaker 2: to get that approval that you need really to get
- 26:36Speaker 2: in the door. So what about Japan B trial?
- 26:40Speaker 3: So Japan B is using the most advanced plasma exchange
- 26:45Speaker 3: or filtration that we have FDA approved. And I've spoken
- 26:48Speaker 3: to a physician who has a pretty high level one
- 26:51Speaker 3: that he's in FDA approval.
- 26:52Speaker 2: Can you explain that, please, to the audience? The plasma exchange.
- 26:56Speaker 2: What does that mean?
- 26:58Speaker 3: So it's all like, so plasma for recess, then plasma absorption,
- 27:02Speaker 3: plasma exchange, it's all in the spectrum, different subtypes. And
- 27:07Speaker 3: I'm learning a lot of this myself, to be honest
- 27:09Speaker 3: with you. So if I make any wrong claims, like,
- 27:13Speaker 3: please bear with me because I've had to learn all
- 27:16Speaker 3: of this. In addition, um, is really cleaning out all
- 27:20Speaker 3: the cytokines and cleaning out all the immunoglobulins and cleaning
- 27:24Speaker 3: out all the amyloid. But there's different levels and specificity.
- 27:29Speaker 3: So the one in Japan, it's high... um, highly specific
- 27:34Speaker 3: to taking out the things that Kevin McCurran has found
- 27:37Speaker 3: in the lab, because he's been researching what is in
- 27:41Speaker 3: the blood of the people that are really sick, right?
- 27:43Speaker 3: So very specific and dual filtration. So just cleaning out
- 27:47Speaker 3: all the junk, right? And then these are just different
- 27:50Speaker 3: types of it, right? So the best possible, um, plasma
- 27:56Speaker 3: cleaning out system that we have in the United States, right?
- 27:59Speaker 3: And then either amniotic stem cells or umbilical cord stem cells, right?
- 28:06Speaker 3: So they're as early on as you can, which some
- 28:09Speaker 3: people would be like, wouldn't they be better than the
- 28:11Speaker 3: tooth stem cells? But Dr. Cato told me that the
- 28:14Speaker 3: baby teeth stem cells are the best for whatever reason.
- 28:17Speaker 3: They've been researching it for decades. And If you ever
- 28:21Speaker 3: talk to Dr. Cato, I trust what that man says
- 28:24Speaker 3: because he knows. His family has owned this private hospital
- 28:27Speaker 3: in Japan for many, many generations. And they took these
- 28:33Speaker 3: researchers and are literally treating the patients there. And just
- 28:36Speaker 3: such an honorable man. I can't even explain how enamored
- 28:40Speaker 3: and grateful I am to know these people.
- 28:43Speaker 2: Well, I hope that you guys get somewhere to help
- 28:46Speaker 2: all of these people that are out there hurting and
- 28:48Speaker 2: really don't have any answers. That seems to be the
- 28:52Speaker 2: common thread between all of the ones that I've talked to,
- 28:55Speaker 2: the ones that I've had come on the show. They
- 28:57Speaker 2: just get frustrated because there are really no answers for them,
- 29:00Speaker 2: and you're trying to provide an answer for them in
- 29:03Speaker 2: these treatments. Let's talk about the different treatment arms. I
- 29:06Speaker 2: know that you discuss this in your paper. Let's talk
- 29:09Speaker 2: about those.
- 29:10Speaker 3: Oh, the third trial is the physiologic optimization trial. So
- 29:16Speaker 3: that's a couple of things. where they do various types
- 29:19Speaker 3: of detox plus they look familiar, like the bromelain. Some
- 29:25Speaker 3: of it has some of the McCullough protocol stuff and
- 29:27Speaker 3: then Pico IV. So these are different things that have
- 29:30Speaker 3: been used, nutraceuticals and other types of treatments that this
- 29:38Speaker 3: protocol is to doctorize. that have been doing this for years, right?
- 29:43Speaker 3: But now we're going to bring them into clinical trials,
- 29:46Speaker 3: bring them into the forefront, show our data, publish our data,
- 29:51Speaker 3: and bring these treatments out to the masses. Because them
- 29:54Speaker 3: just doing it here and there is not helping all
- 29:57Speaker 3: the sick people. And we have to be better scientists
- 29:59Speaker 3: than the predecessors that got us to this point. And
- 30:03Speaker 3: then there's another one called the multimodal trial that uses,
- 30:07Speaker 3: it has four, three arms and it's various types of
- 30:12Speaker 3: nutraceuticals and other types of treatments, more on the complimentary
- 30:17Speaker 3: alternative medicine side. The fifth trial is a platelet rich plasma.
- 30:22Speaker 3: This has been used for years on other types of
- 30:25Speaker 3: vaccine injuries, um, And we want to bring that as
- 30:29Speaker 3: well into the forefront. And then there's another one called Medicinals.
- 30:33Speaker 3: It has a lot of studies in other countries. And
- 30:39Speaker 3: it would be Medicinals versus McCullough. But we might just
- 30:42Speaker 3: do Medicinals versus Placebo. So that's subject to change. And
- 30:46Speaker 3: then I had an email exchange with Dr. McCullough. And
- 30:51Speaker 3: he wants to do McCullough Protocol versus Placebo. So he's
- 30:55Speaker 3: going to work on writing that up. And then there's
- 30:58Speaker 3: a really confidential, controversial study that I'm working on with
- 31:02Speaker 3: another physician that is very important. And we're not ready
- 31:08Speaker 3: to discuss because we have to have all our ducks
- 31:11Speaker 3: in a row regarding it. And then another trial on
- 31:13Speaker 3: the IgE component of the cytokine storm.
- 31:16Speaker 2: Do you know much about platelet-rich plasma trial that's going
- 31:20Speaker 2: on as part of this?
- 31:22Speaker 3: It's not my trial. It's another physician's. It's definitely on
- 31:29Speaker 3: that same spectrum of fixing the infraction of the biochemical
- 31:40Speaker 3: order that happens with the vaccine injury, like trying to
- 31:44Speaker 3: do more of a reset, right?
- 31:47Speaker 1: Yeah.
- 31:47Speaker 3: Does that make sense? This treatment... Like I mentioned, I
- 31:54Speaker 3: know who the physician is, and it's been used for
- 31:57Speaker 3: a while for all the vaccine entries, like I mentioned before.
- 32:02Speaker 3: I deliberately did not put any of the physicians attached
- 32:06Speaker 3: to their trials because some remain behind the scenes still
- 32:12Speaker 3: and are not interested in being public about this until
- 32:16Speaker 3: we go past a grant approval process. So the only
- 32:20Speaker 3: two people that are talking on Twitter and the like
- 32:24Speaker 3: about being principal investigators right now are myself and Dr.
- 32:28Speaker 3: Mary Talen Bowden, who wants to do the Japan A
- 32:31Speaker 3: trial with a couple of other physicians. And so in
- 32:36Speaker 3: conjunction with the Japan training, because some of the physicians
- 32:41Speaker 3: want to wait until we have everything more established before
- 32:45Speaker 3: they're public. So it's not named in there and people
- 32:50Speaker 3: have asked me why. And so I'm trying to get
- 32:52Speaker 3: it out there that we just want to leave these
- 32:54Speaker 3: physicians alone to save lives. And again, Like I said,
- 32:59Speaker 3: I think we're very susceptible to people already trying to
- 33:04Speaker 3: question and things. And so we just want the data
- 33:07Speaker 3: and the clinical trials to speak to ourselves for themselves
- 33:12Speaker 3: and be scientists about it. And most of them really
- 33:14Speaker 3: just couldn't be bothered with the public part of it,
- 33:18Speaker 3: which is, I guess, my job.
- 33:20Speaker 2: Once you get through the process here and we find
- 33:22Speaker 2: something that works and is helping people, how do you
- 33:25Speaker 2: get the word out to all of the other doctors?
- 33:28Speaker 2: I imagine it's through the papers that you guys will
- 33:31Speaker 2: be doing. How will those be dispersed among everybody out
- 33:34Speaker 2: there in the country in the medical profession?
- 33:38Speaker 3: Well, first of all, once we get grant approval, and
- 33:43Speaker 3: let me tell you, the data on the first 14
- 33:46Speaker 3: patients in Japan, it These people are much better after
- 33:53Speaker 3: one series of treatments. I'm going to cry.
- 33:55Speaker 2: I heard the same thing about the antibodies that we
- 34:02Speaker 2: use during COVID. It was the same way. People went
- 34:04Speaker 2: in very sick, and within 30 minutes, an hour, they're
- 34:08Speaker 2: feeling much better. Maybe that's some of what's going on
- 34:11Speaker 2: here with this Japan A trial.
- 34:13Speaker 3: Right. It's like it's like it's based also, if you
- 34:16Speaker 3: think about this, the terrain versus germ theory of disease.
- 34:20Speaker 3: And think about it. If you had a fish in
- 34:24Speaker 3: a fish tank that was really dirty and the fish
- 34:27Speaker 3: was sick, wouldn't you clean out the fish tank at least?
- 34:31Speaker 5: Sure.
- 34:33Speaker 3: So we're kind of cleaning out the fish tank. We
- 34:37Speaker 3: still have other things to do. They still were injected
- 34:39Speaker 3: with synthetic messenger RNA that makes them a spike protein
- 34:43Speaker 3: producing factory plus other contaminants of the COVID biologic mRNA bioweapon.
- 34:49Speaker 3: And the long COVID patients are also included in some
- 34:52Speaker 3: of these because it's the same concept. They're sick. Their
- 34:55Speaker 3: fish tank is dirty, right?
- 34:57Speaker 5: So.
- 34:58Speaker 3: And then the stem cells for the Japan trial is,
- 35:01Speaker 3: you know, to try and reset. And each of these
- 35:03Speaker 3: have various levels of trying to reset and help the
- 35:07Speaker 3: biochemical order and bring them back to health and wellness.
- 35:10Speaker 3: So you have to take out the trash and then
- 35:12Speaker 3: you have to restore health.
- 35:13Speaker 2: Yeah.
- 35:15Speaker 3: I mean, this is not to be honest. This is
- 35:19Speaker 3: all basic medicine. No, no, no. This is... No, no,
- 35:23Speaker 3: it really isn't. Like, I don't know what's wrong with
- 35:26Speaker 3: the world, but this is all based on basic medical
- 35:30Speaker 3: science that we all should understand and know. This is
- 35:34Speaker 3: not anything outside the realm of basic medical understandings. I'm
- 35:40Speaker 3: not sure it freaks me out, like what happened to
- 35:43Speaker 3: the world, really, but this is not out there. And so...
- 35:48Speaker 3: I think it's important for us to understand that the
- 35:51Speaker 3: crime against humanity was injecting an unsafe, untested bioweapon into people.
- 35:55Speaker 3: But the crime against humanity part two is that they
- 35:59Speaker 3: failed to diagnose the vaccine injury. Like, for example, they've
- 36:04Speaker 3: been treating post-vaccination induced myocarditis, the immune side, which is
- 36:09Speaker 3: an autoimmune component of myocarditis, some of the cases. It's
- 36:14Speaker 3: been known for more than a decade or longer with
- 36:17Speaker 3: IV IgG, which is like injecting other immune cells to
- 36:22Speaker 3: neutralize the immune cells that are attacking your system, your
- 36:25Speaker 3: nervous system and your heart. Like those people, if their
- 36:28Speaker 3: symptoms were recognized post-vaccination, they could have had plasmapheresis and
- 36:33Speaker 3: IV IgG and other sorts of things that have been used.
- 36:37Speaker 3: It's been known there's papers on it. Right. But they weren't.
- 36:40Speaker 3: They ignored. And then you get damage. Right. The myocarditis
- 36:43Speaker 3: is inflammation of the heart and attacking of the immune
- 36:46Speaker 3: system of the heart. And then. Not all the cases
- 36:48Speaker 3: are this. This is just one subtype, right? And then
- 36:51Speaker 3: you get heart failure from the damage, which has a
- 36:55Speaker 3: 20% five-year survival rate. But we could have diagnosed the
- 37:01Speaker 3: delay in diagnosis earlier. Failure to provide accurate diagnosis of
- 37:06Speaker 3: a post-injection injury is substandard care. It's not appropriate medicine.
- 37:11Speaker 3: We're supposed to first do no harm and we're supposed
- 37:13Speaker 3: to run the differential diagnosis and see what's wrong with
- 37:15Speaker 3: the patient. But because for some reason, narrative is that
- 37:19Speaker 3: you can't get hurt from something that's injected to you.
- 37:21Speaker 3: It's absurd because I do spinal injections and I provide
- 37:24Speaker 3: informed consent and I literally tell people that they can
- 37:27Speaker 3: have problems and side effects, some of them horrible.
- 37:29Speaker 5: Yeah.
- 37:31Speaker 2: Her name is Dr. Irene Mavrikakis, and she is doing this.
- 37:36Speaker 2: Vaccine Injury Treatment Center of Excellence and Research Clinical Trial
- 37:41Speaker 2: Consortium or Consortium, however you want to say it. We
- 37:45Speaker 2: discovered tonight that either way is just fine. Don't worry
- 37:48Speaker 2: about it. The important thing is go to givebutter.com and
- 37:51Speaker 2: find this. If you want to help, if you want
- 37:54Speaker 2: to help, it'd be great. so that they can get
- 37:56Speaker 2: off the ground to start helping people that have been
- 37:59Speaker 2: vaccine injured, whether it was COVID-19 or any other vaccine injury,
- 38:03Speaker 2: because there are a lot. It's not just COVID-19 vaccine. Again,
- 38:07Speaker 2: it's the Vaccine Injury Treatment Center of Excellence and Research
- 38:11Speaker 2: Clinical Trial Consortium. And Dr. Irene Mavrikakis, tell us again
- 38:17Speaker 2: your Twitter handle, because you mentioned it is the best
- 38:19Speaker 2: place to kind of reach out to you and find
- 38:21Speaker 2: information about this. So please do that for us.
- 38:25Speaker 3: Yeah, it's at Irene Mavropakis. And the other place that
- 38:30Speaker 3: you can find a little blurb about the consortium is
- 38:37Speaker 3: on a Coalition of the Free website, Coalition of the Free.
- 38:42Speaker 3: And there's a little page, a landing page on Coalition
- 38:47Speaker 3: of the Free that goes over... the consortium and has
- 38:51Speaker 3: a link to the give butter, but if they just
- 38:54Speaker 3: go on Twitter and find me, they can find the
- 38:56Speaker 3: gift butter and we only launched it. Um, let's see.
- 39:00Speaker 2: You're doing great. You're doing great. When last Thursday you're
- 39:06Speaker 2: doing fantastic raising money.
- 39:09Speaker 1: Oh, I'm sorry.
- 39:10Speaker 5: Yeah.
- 39:10Speaker 3: We're halfway. I think we're like at 14,000 plus, you know,
- 39:14Speaker 3: reading the comments, you know, I cry every couple of
- 39:17Speaker 3: hours and then I, Thank each one of them. And
- 39:21Speaker 3: it's just amazing that we're doing this. And my libertarian
- 39:28Speaker 3: heart is happy actually to be doing this in a
- 39:32Speaker 3: decentralized private way. It really is just a wonderful idea
- 39:40Speaker 3: that really we should just do this on its own.
- 39:42Speaker 3: And I think that's the epiphany for me.
- 39:44Speaker 2: I think it kind of worked out the way that
- 39:46Speaker 2: it was supposed to, don't you?
- 39:49Speaker 3: Yeah, I mean, you know, you kind of know me
- 39:51Speaker 3: well enough. I'm not really sure that I like to
- 39:53Speaker 3: be told what to do. Coalitionofthefree.com, which is a coalition
- 40:01Speaker 3: that I started with the national chair of the We
- 40:04Speaker 3: the People Party and RLC, Republican Liberty Caucus is involved.
- 40:08Speaker 3: And we're working on candidates to get elected in the
- 40:12Speaker 3: state and federal houses that are not corrupted and captured.
- 40:14Speaker 3: But When we if you go to the our coalition page,
- 40:18Speaker 3: we put a whole landing page on the consortium with
- 40:23Speaker 3: extra information and a link to the give butter. So
- 40:27Speaker 3: that's at coalition of the free dot com. And then
- 40:31Speaker 3: if you click on the our coalition button, that's also
- 40:35Speaker 3: a good place to and easy to remember other than
- 40:38Speaker 3: at Irene Mavrikakis Twitter.
- 40:41Speaker 2: Irene, thank you so much, friend, for coming on the
- 40:43Speaker 2: program and sharing all of this information. I appreciate you
- 40:46Speaker 2: coming on the program.
- 40:48Speaker 3: Well, thanks so much, Booker. And I really appreciate your
- 40:50Speaker 3: friendship and you being my colleague and Liberty and all
- 40:54Speaker 3: the other shenanigans we get into.
- 40:58Speaker 2: Okay, well, have a great night. I appreciate it.
- 41:00Speaker 3: Thank you so much, Booker.
- 41:02Speaker 4: I don't know about you, but the one thing the
- 41:03Speaker 4: last five or so years has taught me is that
- 41:05Speaker 4: there's a lot, and I mean a lot, of companies
- 41:08Speaker 4: and services out there that don't share the foundational values
- 41:11Speaker 4: of this country and we the people. And I've spoken
- 41:13Speaker 4: to a lot of you about it who share the
- 41:15Speaker 4: same concerns, and you wonder where to shop, where to
- 41:18Speaker 4: spend your hard-earned money without feeling gross about it.
- 41:20Speaker 1: It can be frustrating, but here's the good news.
- 41:23Speaker 4: You don't have to do the research yourself and you
- 41:25Speaker 4: don't have to tie yourself up in.
- 41:26Speaker 1: Knots any longer because we've done the legwork for you.
- 41:29Speaker 4: At mammothnation.com, we have thousands of vetted, freedom-loving, pro-America companies
- 41:34Speaker 4: who actually share your values.
- 41:36Speaker 1: So now the ball's in your court.
- 41:37Speaker 4: Keep spending money with companies that frustrate you and then
- 41:40Speaker 4: use the proceeds to fund initiatives that are in direct
- 41:42Speaker 4: competition with your values or be a part of something better.
- 41:46Speaker 1: I think the choice is pretty easy. Come be a
- 41:48Speaker 1: part of the solution.
- 41:49Speaker 4: Join Mammoth Nation today and you can save 30% off
- 41:52Speaker 4: your membership by using promo code USA.
- 42:12Speaker 2: You know, when we came through COVID, What a mess
- 42:15Speaker 2: it was. And I think it scarred so many of
- 42:18Speaker 2: us in so many different ways. When you think about
- 42:21Speaker 2: the kids in school and not being in school socially,
- 42:24Speaker 2: they've probably been set back forever. But it affected adults also.
- 42:28Speaker 2: And one of those adults that was affected greatly coming
- 42:32Speaker 2: through that mess was Dr. Dawn Michael. And I want
- 42:36Speaker 2: her to share her story about what happened, what she
- 42:39Speaker 2: went through. She's very outspoken. was outspoken on social media.
- 42:43Speaker 2: You may remember the name, but let's find out also
- 42:46Speaker 2: what she's doing today and how her life is going.
- 42:50Speaker 2: So let me introduce you to Dr. Dawn Michael. Dr. Michael,
- 42:54Speaker 2: thank you for joining us.
- 42:55Speaker 5: Thank you for having me on. I appreciate the fact
- 42:59Speaker 5: that you're allowing me to tell my story and really
- 43:04Speaker 5: get the word out. And part of why I continue
- 43:08Speaker 5: to push on Twitter, and that's the platform I've been using.
- 43:12Speaker 5: I'm also on Getter, and I have a YouTube channel,
- 43:16Speaker 5: is because the drug remdesivir, which is responsible for killing
- 43:23Speaker 5: my husband, and also they gave it to me without
- 43:27Speaker 5: my consent. So I had two doses that affected my
- 43:31Speaker 5: health after I got out of the hospital. And the
- 43:34Speaker 5: shocking thing is they continue to use it in hospitals today.
- 43:39Speaker 5: And it's been approved for infants and children.
- 43:42Speaker 2: Well, let's go back to the beginning of your story
- 43:45Speaker 2: and kind of tell people about that. What happened? Because
- 43:49Speaker 2: as I remember, because I was I didn't know you
- 43:52Speaker 2: at the time, but I was watching you on social
- 43:55Speaker 2: media and it was gut wrenching. Tell everybody what happened.
- 43:59Speaker 5: So my husband was a family practice doctor. He escaped Cuba.
- 44:04Speaker 5: So he came over here a while ago. He was
- 44:09Speaker 5: 62 when he passed away. So he slowly felt a
- 44:14Speaker 5: little bit of communism, socialism creeping in. He felt it
- 44:17Speaker 5: a long time ago, maybe 10, 12 years ago. And
- 44:22Speaker 5: at the time when COVID hit, I remember him and I,
- 44:26Speaker 5: we had this discussion because we had an office together.
- 44:28Speaker 5: I did the mental health. He did the family practice.
- 44:35Speaker 5: And we said, why are they ushering this vaccine out
- 44:38Speaker 5: so quickly? It hasn't gone through, in his terms, the
- 44:40Speaker 5: honeymoon period.
- 44:43Speaker 2: That's a natural question back then. I remember thinking the
- 44:46Speaker 2: same thing. All of these other vaccines have taken all
- 44:49Speaker 2: of these years to get approval from If we can
- 44:51Speaker 2: approve this one in six months, how come we can't
- 44:54Speaker 2: approve others in six months? But sorry for the interruption.
- 44:57Speaker 2: Keep going, please.
- 44:59Speaker 5: Yes, and that to me should have been a question
- 45:01Speaker 5: on every doctor's mind. Like, why isn't every doctor? But
- 45:05Speaker 5: the reason I know that he asked it because he
- 45:08Speaker 5: had his own family practice. He wasn't in a group.
- 45:11Speaker 5: They weren't telling him what to do. He was a
- 45:13Speaker 5: doctor who thought outside of the box. And so for him,
- 45:17Speaker 5: he also developed his own protocol using ivermectin. And other
- 45:23Speaker 5: doctors around the area were not able to do that
- 45:26Speaker 5: because they were getting penalized for using ivermectin. But because
- 45:30Speaker 5: he wasn't in the system, and I'm just going back
- 45:34Speaker 5: a little, but people need to understand this, that when
- 45:37Speaker 5: Obama said all the medical doctors need to put their
- 45:39Speaker 5: records into the system, Those records became known through COVID.
- 45:46Speaker 5: So they were able to track which doctors were giving
- 45:48Speaker 5: patients ivermectin and that's how they did it. And so
- 45:52Speaker 5: at the time, my husband had so many files. He'd
- 45:55Speaker 5: already been in a family practice for some 30 years.
- 45:58Speaker 5: He never put them in the system. So they didn't
- 46:01Speaker 5: come after him for that. And he was able to
- 46:04Speaker 5: find a small compound pharmacy and give his patients ivermectin. Now,
- 46:10Speaker 5: the hospital that he sent a few of his patients to,
- 46:14Speaker 5: and mind you, I think almost every single one of them,
- 46:18Speaker 5: which was only nine, came out of the hospital alive
- 46:21Speaker 5: because he was their patient advocate. And he spoke to
- 46:26Speaker 5: a hospitalist there. I would hear him up at night
- 46:30Speaker 5: talking to the hospitalist, telling him how to treat his patients.
- 46:34Speaker 5: And I don't think that they liked that because they
- 46:37Speaker 5: get a lot of money when they give the patients
- 46:40Speaker 5: in their remdesivir and do the hospital protocol then and
- 46:44Speaker 5: they die. I mean, that happens to so many of
- 46:46Speaker 5: the patients who end up in the hospital. In any event,
- 46:51Speaker 5: he knew the hospitalists for 20 years. He knew all
- 46:54Speaker 5: of them because he had assisted in surgery at this
- 46:57Speaker 5: particular hospital, which is Los Robles Hospital in Thousand Oaks,
- 47:01Speaker 5: which has a very bad reputation right now. But in
- 47:04Speaker 5: any event, he had been treating his patients for two years.
- 47:09Speaker 5: We thought that we had had COVID in the very beginning.
- 47:12Speaker 5: I still think we did. But I think when the
- 47:16Speaker 5: Delta variant came out, I believe personally it was a
- 47:19Speaker 5: different bioweapon because it affected both of us in a
- 47:23Speaker 5: very different way.
- 47:24Speaker 2: Yeah, I had that strain and it was no fun.
- 47:28Speaker 3: It was bad.
- 47:28Speaker 2: And My oxygen level dropped down to 82 for a
- 47:33Speaker 2: couple of days. And I called my doctor and told her,
- 47:38Speaker 2: and she said, you need to get to the emergency room.
- 47:40Speaker 2: And I'm like, no, thank you. I have no intention
- 47:43Speaker 2: of going to the emergency room. And I asked her,
- 47:45Speaker 2: I said, how many patients have you sent to the hospital?
- 47:50Speaker 2: She said several. I said, have any died? She said, yes.
- 47:53Speaker 2: I said, have any of your patients not gone to
- 47:55Speaker 2: the hospital? She said, yes. I said, how many died?
- 47:58Speaker 2: She said, none.
- 47:59Speaker 5: None.
- 48:00Speaker 2: And I said, thank you. I'll stay home. And in
- 48:03Speaker 2: a day or so, it was better. But go ahead.
- 48:06Speaker 2: I'm sorry.
- 48:07Speaker 5: No, you're exactly correct. But the situation is... It came
- 48:13Speaker 5: on as a fever. We thought it was the flu because,
- 48:18Speaker 5: of course, we thought we had had COVID and he'd
- 48:20Speaker 5: been treating patients with COVID for two years. So why
- 48:23Speaker 5: would we think that this would be COVID? We thought,
- 48:26Speaker 5: you know, we had the antibodies. Neither one of us
- 48:28Speaker 5: were vaccinated. And for a doctor, that was rare. I
- 48:32Speaker 5: didn't believe in the vaccine. And he was one of
- 48:35Speaker 5: the few doctors that didn't even recommend the vaccine. He
- 48:38Speaker 5: just would... send them a video to watch. It was
- 48:41Speaker 5: usually one of Dr. Peter McCullough's videos. He's like, watch
- 48:44Speaker 5: this to get the other side.
- 48:45Speaker 2: Okay.
- 48:47Speaker 5: But in any event, we both got it. He got
- 48:50Speaker 5: it first. And just like you said, it attacks the
- 48:53Speaker 5: lower lungs. So it was, and it comes on like,
- 48:57Speaker 5: I mean, it Yeah, me neither. And then it went
- 49:10Speaker 5: away for a day, which was so strange. And then
- 49:14Speaker 5: it came back and it happened to with the oxygen.
- 49:18Speaker 5: So he couldn't breathe. We got an oxygen tank at home,
- 49:23Speaker 5: but it wasn't the ones that the hospitals have. And
- 49:26Speaker 5: that's really what he needed. So this was, I think.
- 49:32Speaker 5: I think it was day nine. Finally, I told him
- 49:34Speaker 5: to start the protocol on day seven. I said, just think,
- 49:38Speaker 5: you know, you have COVID, whatever it is, just start
- 49:40Speaker 5: your protocol. But he did. And it got to a
- 49:45Speaker 5: point where his oxygen level went below, I think it
- 49:48Speaker 5: was 80. And he literally wasn't breathing. And he said,
- 49:52Speaker 5: you have to take me to the hospital. I just
- 49:55Speaker 5: I'm going to die. And I was so resistant. I'm like,
- 49:58Speaker 5: I can't bring you to the hospital because I don't
- 50:00Speaker 5: think you're going to come out of the hospital. I
- 50:02Speaker 5: told him that. But in any event, I took him
- 50:05Speaker 5: to the hospital. They wouldn't let me in with him.
- 50:07Speaker 5: He went into the emergency, which was a complete nightmare.
- 50:13Speaker 5: They had him there for, I don't even know, maybe 10,
- 50:17Speaker 5: 11 hours before they even gave him a bed. And
- 50:20Speaker 5: once they did that, I had called the nurses and
- 50:23Speaker 5: the doctors and I'm like, do not give him remdesivir.
- 50:26Speaker 5: Do not. Like I already knew. Do not give it
- 50:28Speaker 5: to him. And the nurses assured me that they didn't
- 50:32Speaker 5: give him remdesivir, which they lied because as I found
- 50:37Speaker 5: out later, they had given him remdesivir and he was
- 50:41Speaker 5: pretty out of it. So I think for the first
- 50:44Speaker 5: two days he was in there.
- 50:46Speaker 2: So did they put him on the ventilator? As well?
- 50:49Speaker 5: Well, it didn't get to that point yet. It didn't
- 50:52Speaker 5: happen yet. So he was in the hospital for nine days. Um,
- 50:58Speaker 5: what the next is I got the same, you know,
- 51:01Speaker 5: I got the Delta and I wasn't doing very well,
- 51:04Speaker 5: but I certainly didn't need to go to the hospital,
- 51:07Speaker 5: but he, we were texting back and forth. He's like,
- 51:09Speaker 5: you have to come to the hospital. And then my neighbor,
- 51:12Speaker 5: who's a paramedic. And then my son, they just were
- 51:15Speaker 5: so worried about me that they kind of insisted go
- 51:18Speaker 5: to the hospital. So I went in an ambulance to
- 51:21Speaker 5: the hospital, same horror story in the waiting room and Um,
- 51:26Speaker 5: where people were sitting in wheelchairs on the ground on gurneys. Um,
- 51:31Speaker 5: and they were only wearing masks in there, by the way. And, um,
- 51:35Speaker 5: I remember they asked me if I was vaccinated and
- 51:39Speaker 5: I made the mistake and I said, No, at first.
- 51:43Speaker 5: And I was just treated very poorly. They didn't give
- 51:46Speaker 5: me water. They didn't come check me. And when they
- 51:49Speaker 5: went to give me the COVID test, finally, I refused it.
- 51:54Speaker 5: So I never did have a COVID test. But in
- 51:56Speaker 5: the meantime, they put me in a room with three
- 51:59Speaker 5: other people that didn't have COVID. So how worried were
- 52:02Speaker 5: they that it was this infectious spreading virus when I
- 52:06Speaker 5: was in there with two other people? And they only
- 52:09Speaker 5: had masks on, which the doctors were wearing in a
- 52:11Speaker 5: flimsy way. So at this point, my husband's upstairs on
- 52:15Speaker 5: the third floor. Finally, after I think it was 10
- 52:18Speaker 5: hours for me, nine hours later, They wheeled me up
- 52:22Speaker 5: to the third floor and they had said they didn't
- 52:24Speaker 5: have any beds, which was totally false. They had tons
- 52:28Speaker 5: of beds. They had no staff. So they had fired
- 52:31Speaker 5: the staff that wasn't vaccinated. And right at that time,
- 52:34Speaker 5: if you remember, it was like Omicron came on and
- 52:37Speaker 5: a lot of the people were sick. So they had
- 52:41Speaker 5: one charge nurse to about, I don't even know, 10 patients,
- 52:46Speaker 5: like so understaffed. But the inconsistency was downstairs. They had
- 52:51Speaker 5: just a mask and upstairs they were wearing these full
- 52:55Speaker 5: on hazmat suits. I mean, it's right, right. Like it's
- 52:59Speaker 5: going to change.
- 53:00Speaker 2: Um, yeah, it was such theater, wasn't it?
- 53:04Speaker 5: Oh my God.
- 53:05Speaker 3: Yeah.
- 53:06Speaker 2: And then, and then what, what ended up happening to
- 53:09Speaker 2: your husband in that hospital stay?
- 53:12Speaker 5: So, um, What happened is, I'm just going to go
- 53:16Speaker 5: real quick into this. Just to finish my story with myself,
- 53:21Speaker 5: because it kind of coincides with him. Sure. The doctor
- 53:23Speaker 5: that was treating him, They had given me remdesivir the
- 53:28Speaker 5: day I got there and then the next day without
- 53:31Speaker 5: my consent. And this is a huge thing. I did
- 53:34Speaker 5: not consent. Nobody told me they were giving me remdesivir.
- 53:37Speaker 5: When I finally found out, I freaked out. And I
- 53:40Speaker 5: said to the doctor, because it is in their protocol,
- 53:44Speaker 5: like you're not supposed to give somebody remdesivir unless it's
- 53:48Speaker 5: like two or three days that they've had COVID. And
- 53:51Speaker 5: I said I had had it five days prior. So
- 53:53Speaker 5: then the doctor agreed, oh yeah, you don't need the remdesivir.
- 53:56Speaker 5: And I said to him, but my husband had it
- 53:58Speaker 5: nine days prior and you at this point had given
- 54:01Speaker 5: him five doses of remdesivir. So the doctors knew. They
- 54:05Speaker 5: knew that the chances of at least 30 to 40%
- 54:09Speaker 5: of the people they gave it to were going to die.
- 54:11Speaker 5: And my husband, as I found out, he did have
- 54:15Speaker 5: some kidney issues and they knew that. So for him,
- 54:18Speaker 5: it was a death sentence, an absolute death sentence.
- 54:22Speaker 2: And ultimately, that's what happened, isn't it?
- 54:25Speaker 5: That's what happened. And these were his colleagues. These are
- 54:29Speaker 5: his colleagues. That's what makes it so insane.
- 54:31Speaker 2: Do you think it was just ignorance on their part?
- 54:35Speaker 5: No, I do not. I do not. Remember, he wasn't
- 54:39Speaker 5: sending people to the hospital. They were not making profits
- 54:43Speaker 5: off of his patients. And he was, you know, he
- 54:46Speaker 5: had a lot of patients. So in the end, I
- 54:51Speaker 5: was there on day five. And the day before, he
- 54:56Speaker 5: texted me. I have all of his text messages and
- 54:58Speaker 5: everything from when we were there. He said to me
- 55:00Speaker 5: they called in a kidney specialist because his kidney was
- 55:04Speaker 5: failing day nine, which is what happens with remdesivir. And
- 55:09Speaker 5: then he said, I don't think I'm going to make it.
- 55:12Speaker 5: And I for the five days I was there, I
- 55:15Speaker 5: kept asking if I could see him. Remember, he was
- 55:17Speaker 5: across the hall. At one point, they drugged me so
- 55:20Speaker 5: that I couldn't get out of bed because I tried
- 55:22Speaker 5: to go over to see him. So that was another
- 55:26Speaker 5: absolutely cruel thing is they wouldn't let us see each
- 55:29Speaker 5: other on the same floor. So then came in on
- 55:32Speaker 5: day five.
- 55:33Speaker 3: I was there.
- 55:35Speaker 5: And they said to me that he had gone into
- 55:38Speaker 5: cardiac arrest. And I told them they better get me
- 55:42Speaker 5: down to see him. So they went to get me
- 55:44Speaker 5: a wheelchair. And by the time they put me in
- 55:47Speaker 5: the wheelchair, he had already passed.
- 55:49Speaker 2: Yeah, that was awful.
- 55:52Speaker 5: I never got to say goodbye to him. Thank you
- 55:54Speaker 5: so much for having me on. And God bless you too,
- 55:57Speaker 5: you know, people like you who are doing podcasts. And,
- 56:00Speaker 5: you know, we're all in this together. And one thing
- 56:02Speaker 5: I will say... What happens in California affects the rest
- 56:06Speaker 5: of the country. So it's really important that we we
- 56:11Speaker 5: all work together on medical freedom and parental rights and everything,
- 56:16Speaker 5: you know, that I think all of us believe in.
- 56:19Speaker 2: Dawn, thank you so much. There is only one truth.
- 56:24Speaker 2: You've been listening to The Truth Be Told with Booker
- 56:27Speaker 2: Scott on America Out Loud.